Our hidden viruses in our DNA can be the next large penetration of medicine

8 percent of your DNA – viral bits – silence is usually silent. Scientists call it part of the “dark matter” in the genome.

Now the scientists at the La Jolla Institute of Immunity (LJI) have published a first look at the main viral protein. In a study published in Science progress, Lji researchers revealed the first 3D structure of a protein from one of these “human genetic viruses (HEVS)”.

The team has planned the surface cover protein (ENV), which is the target of the most active antibodies to the antibody, and represents a milestone in structural biology. “This is the first Human Herv Protein Structure Ever Solved – and only the Third Retroviron Enable Struckure Solved Overall, After Human Immunodeficience Virus (HIV) and Simian IMMUNODEFICIECY VIRUS (SIV), “Says Erica Olmann Saphire, Ph.d., MBA, Lji President, CEO, and Professor.

This discovery opens the door to new strategies to diagnose and treat the disease. Again in the evolutionary past, hurt-k env proteins are lured outside the HERV-K viruses. But in modern humans, HERV-K ENV proteins appear on the surface of some cancer cells and in patients with autoimmune diseases and nervous degeneration, making them an important target for developing new diagnoses and treatments.

“In many conditions, such as autoimmune diseases and cancer, these genes re -wake them up and begin to make parts of these viruses,” Safeer says. “Understand HERV-K ENV, and the antibodies that we have now, open diagnostic and treatment chances.”

An unexpected “development”

To date, HERV proteins have been invisible. They have proven that the mobile – and they have severe – cannot be seen even with the most advanced photography techniques. The HERV-K ENV structure was particularly difficult because the LJI team needed to pick up the sensitive “before melting” protein.

Embellic proteins are full of underlying energy-which is mainly loaded with integration with a hostess to start the infection process. This means that before melting proteins are subject to automatic switching to their subsequent condition after fusion. “You can look at them funny, and will be revealed,” says Jeremy Chic, his L -Gi, his post -PhD colleague, says.

To study the 3D installation of HERV-K ENV, researchers inserted small alternatives to lock the protein structure in place, while maintaining its natural shape. Safeer and her team have previously used this approach to unveil the main protein structures on the Ebola virus, Lata virus and more. Researchers also discovered and distinguished counter -antibodies that helped consolidate various versions of viral proteins.

After installing their HERV-K ENV structures, the LJI team used a high-resolution imaging technology called CRYO electron to take 3D HERV-K ENV in three main moments: the surface of the cell, in the act of an infection, and when the antibodies disappear.

Many sugary proteins for viral virals have a TRIMER, but HERV-K Env is different from anything that scientists have seen before, including the pieces of other reading and recovery viruses. Unlike the short pieces made by HIV and SIV, HERV-K ENV is tall. Moreover, the protein fold – weave the threads and files that build the work machine – is not similar to any Rittros virus.

A new way for clinical research

The new LJI study opens the door to use HERV-K Env for our benefit. Understanding HERV-K ENV, and how to target antibodies, may be useful for developing diagnostic tools or new treatments.

For example, many types of cancer cells-from breast cancers to ovarian cancers-but not healthy cells, spread with HERV-K En This means that antibodies against HERV can distinguish cancer cells from healthy cells. As SUN explains, scientists can develop immune treatments for cancer that reaches HERV-K ENV to track down cancer cells. “We can use it as a strategy to target cancer cells specifically,” says Sun.

People with autoimmune diseases such as lupus or rheumatoid arthritis also express ENC HERV-K on their cells. Some scientists suspect that the immune cells of patients see these exotic proteins and believe that the body is being attacked. As during natural viral infection, their B cells begin to make antibodies against HERV-K ENV.

“Understanding how to identify the antibodies to these proteins was a challenge because there was no good structure and good antibodies so far available,” Safeer says.

So, the LJI team made a plate of their antibodies to detect how to target the immune system of the different sub -units of the molecule in all its different forms. Once scientists understand how these antibody attacks work, they can try to intervene and stop harmful inflammation.

Scientists have also tested the idea that their antibodies may also be useful tools for diagnosing many autoimmune diseases. They used antibodies to try to search for immune cells in samples of patients with rheumatoid and lupus arthritis. When Saphire and her colleagues put a mark on these antibodies with molecular flag, they managed to discover HERV-K ENV quickly on neutrophils, a type of immune cell that can cause inflammation.

“These antibodies were characterized by anomalous HERV width on neutrophils from rheumatoid arthritis and lupus patients, but not health control items,” Safeer says.

Hervs grows rapidly, and scientists find more and more diseases in which hev-K Env. “We can really choose any disease interested in it and go to this way,” says Chic.

These projects may one day provide clinical care – and our primary understanding of human biology. After all, we are all virus. It’s time to get to know this part of ourselves.

Adruvirus K (HERV-K) additional authors in the pre-merger by Cryo-Im. Cassandra Yu, Kelly every codes, Victoria E. Lewis, Robin Diaz Avalos, and Thomas Mostaline,

This study was supported by the Curebound Discover grant (13502-01-408) and Lji & Kyowa Kirin, Inc.